Effects of cytokines on carbon tetrachloride-induced hepatic fibrogenesis in rats

World Journal of Gastroenterology

Volumn 10, Issue 1, 2004, Pages 77-81

  Zhang, Li Juan ^a   Yu, Jie Ping ^a   Li, Dan ^b   Huang, Yue Hong ^b  

^a WUHAN UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; COLLAGEN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROGENESIS; INTOXICATION; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER PARENCHYMA; NONHUMAN; PROTEIN BLOOD LEVEL; RANDOMIZATION; RAT;

EID: 0347946703     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i1.77     Document Type: Article

References (42)

1. Friedman SL. Molecular mechanisms of hepatic fibrosis and principles of therapy. J Gastroenterol 1997; 32: 424-430
2. Du WD, Zhang YE, Zhai WR, Zhou XM. Dynamic changes of type I, III and IV collagen synthesis and distribution of collagen-producing cells in carbon tetrachloride-induced rat liver fibrosis. World J Gastroenterol 1999; 5: 397-403
3. Wang JY, Guo JS, Yang CQ. Expression of exogenous rat collagenase in vitro and in a rat model of liver fibrosis. World J Gastroenterol 2002; 8: 901-907
4. Friedman SL. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis: Mechanisms and treatment strategies. N Engl J Med 1993; 328: 1828-1835
5. Abdel-Aziz G, Lebeau G, Rescan PY, Clement B, Rissel M, Deugnier Y, Campion JP, Guillouzo A. Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat. Am J Pathol 1990; 137: 1333-1342
6. Nakamura T, Sakata R, Ueno T, Sata M, Ueno H. Inhibition of transforming growth factor β prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats. Hepatology 2000; 32: 247-255
7. Shi J, Aisaki K, Ikawa Y, Wake K. Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tetrachloride. Am J Pathol 1998; 153: 515-525
8. Friedman SL. Cytokines and fibrogenesis. Semin Liver Dis 1999; 19: 129-140
9. Koziel JK. Cytokines in viral hepatitis. Semin Liver Dis 1999; 19: 157-169
10. Bissell DM, Roulot D, George J. Transforming growth factor β and the liver. Hepatology 2001; 34: 859-867
11. Kovalovich K, DeAngelis RA, Li W, Furth EE, Ciliberto G, Taub R. Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology 2000; 31: 149-159
12. Yoshidome H, Kato A, Edwards MJ, Lentsch AB. Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: Implications of a central role for nuclear factor κB. Hepatology 1999; 30: 203-208
13. Morrow JD, Awad JA, Kato T, Takahashi K, Badr KF, Robert LJ 2nd, Burk KF. Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation. J Clin Invest 1992; 90: 2502-2507
14. Nelson DR, Lauwers GY, Lau JY, Davis G. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: A pilot trial of interferon nonresponders. Gastroenterology 2000; 118: 655-660
15. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-435
16. Tsukamoto H, Matsuoka M, French SW. Experimental models of hepatic fibrosis: A review. Semin Liver Dis 1990; 10: 56-65
17. Missale G, Ferrari C, Fiaccadori F. Cytokine mediators in acute inflammation and chronic course of viral hepatitis. Ann Ital Med Int 1995; 10: 14-18
18. Davis BH, Kresina TF. Hepatic fibrogenesis. Clin Lab Med 1996; 16: 361-375
19. Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur MJ. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998; 102: 538-549
20. Nakamura T, Sakata R, Ueno T, Sata M, Ueno H. Inhibition of transforming growth factor β prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats. Hepatology 2000; 32: 247-255
21. Dooley S, Delvoux B, Lahme B, Mangasser-Stephan K, Gressner AM. Modulation of transforming growth factor β response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts. Hepatology 2000; 31: 1094-1106
22. Garcia-Trevijano ER, Iraburu MJ, Fontana L, Dominguez-Rosales JA, Auster A, Covarrubias-Pinedo A, Rojkind M. Transforming growth factor β1 induces the expression of α1 (I) procollagen mRNA by a hydrogen peroxide-C/EBP β-dependent mechanism in rat hepatic stellate cells. Hepatology 1999; 29: 960-970
23. Si XH, Yang LJ. Extraction and purification of TGFβ and its effect on the induction of apoptosis of hepatocytes. World J Gastroenterol 2001; 7: 527-531
24. Bissell DM, Wang SS, Jarnagin WR, Roll FJ. Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest 1995; 96: 447-455
25. Knittel T, Janneck T, Muller T, Fellmer P, Ramadori G. Transforming growth factor beta 1-regulated gene expression of Ito cells. Hepatology 1996; 24: 352-360
26. Llorent L, Richaud-Patin Y, Alcocer-Castillejos N, Ruiz-Soto R, Mercado MA, Orozco H, Gamboa-Dominguez A, Alcocer-Varela J. Cytokine gene expression in cirrhotic and non-cirrhotic human liver. J Hepatol 1996; 24: 555-563
27. Zhang GL, Wang YH, Teng HL, Lin ZB. Effects of aminoguanidine on nitric oxide production induced by inflammatory cytokines and endotoxin in cultured rat hepatocytes. World J Gastroenterol 2001; 7: 331-334
28. Roberts RA, James NH, Cosulich SC. The role of protein kinase B and mitogen-activated protein kinase in epidermal growth factor and tumor necrosis factor α-mediated rat hepatocyte survival and apoptosis. Hepatology 2000; 31: 420-427
29. Crespo J, Cayon J, Fernandez-Gil P, Hernandez-Guerra M, Mayorga M, Dominguez-Diez A, Fernandez-Escalante JC, Pons-Romero F. Gene expression of tumor necrosis factor α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 2001; 34: 1158-1163
30. Hernandez-Munoz I, De La Torre P, Sanchez-Alcazar JA, Garcia I, Santiago E, Munoz-Yague MT, Solis-Herruzo JA. Tumor necrosis factor α inhibits collagen α1 (1) gene expression in rat hepatic stellate cells through a G protein. Gastroenterology 1997; 113: 625-640
31. Selzner M, Camargo CA, Clavien PA. Ischemia impairs liver regeneration after major tissue loss in rodents: Protective effects of interlukin-6. Hepatology 1999; 30: 469-475
32. Sakamoto T, Liu Z, Murase N, Ezure T, Yokomuro S, Poli V, Demetris AJ. Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. Hepatology 1999; 29: 403-411
33. Peters M, Blinn G, Jostock T, Schirmacher P, Meyer Zum Buschenfelde KH, Galle PR, Rose-John S. Combined interleukin-6 and soluble interleukin-6 receptor accelerates murine liver regeneration. Gastroenterol 2000; 119: 1663-1671
34. Wang JY, Wang XL, Lin P. Detection of serum TNF-α, IFN-γ, IL-6 and IL-8 in patients with hepatitis B. World J Gastroenterol 1999; 5: 38-40
35. Zhen Z, Zhou JY, Liu JX, Hong ZJ, Pei X. Relationship between IL-6 and SIL-6R and their pathogenicity in viral hepatitis. Shijie Huaren Xiaohua Zazhi 2000; 8: 1434-1435
36. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, Taub R. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996; 274: 1379-1383
37. Natsume M, Tsuji H, Harada A, Akiyama M, Yano T, Ishikura H, Nakanishi I, Matsushima K, Kaneko S, Mukaid N. Attenuated liver fibrosis and depressed serum albumin levels in carbon tetrachloride-treated IL-6-deficient mice. J Leukoc Biol 1999; 66: 601-608
38. Louis H, Le Moine O, Peny MO, Gulbis B, Nisol F, Goldman M, Deviere J. Hepatoprotective role of interleukin 10 in galactosamine/lipopolysaccharide mouse liver injury. Gastroenterology 1997; 112: 935-942
39. Reitamo S, Remitz A, Tamai K, Uitto J. Interleukin-10 modulates type 1 collagen and matrix metalloprotease gene expression in cultured human skin fibroblasts. J Clin Invest 1994; 94: 2489-2492
40. Thompson K, Maltby J, Fallowfield J, McAulay M, Millward-Sadler H, Sheron N. Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis. Hepatology 1998; 28: 1597-1606
41. Louis H, Van Laethem JL, Wu W, Quertinmont E, Degraef C, Van Den Berg K, Demols A, Goldman M, Le Moine O, Geerts A, Deviere J. Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice. Hepatology 1998; 28: 1607-1615
42. 4. World J Gastroenterol 2003; 9: 539-543